High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2160-2165

  Chen, Meng ^a   Kamat, Ashish M ^a   Huang, Maosheng ^a   Grossman, H B ^a   Dinney, Colin P ^a   Lerner, Seth P ^b   Wu, Xifeng ^a   Gu, Jian ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTERASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 6; HELICASE; NUCLEIC ACID BINDING PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAD23B PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; DATA MINING; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE DOSAGE; GENE INTERACTION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA REPAIR; DNA, NEOPLASM; GENE AMPLIFICATION; GENOTYPE; HUMANS; NEOPLASM INVASIVENESS; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS; SMOKING; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 35148822240     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm167     Document Type: Article

References (33)

1. Hoeijmakers,J.H. (2001) Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-374.
2. Berwick,M. et al. (2000) Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review. J. Natl Cancer Inst. 92, 874-897.
3. Wood,R.D. et al. (2001) Human DNA repair genes. Science, 291, 1284-1289.
4. Christmann,M. et al. (2003) Mechanisms of human DNA repair: An update. Toxicology, 193, 3-34.
5. Volker,M. et al. (2001) Sequential assembly of the nucleotide excision repair factors in vivo. Mol. Cell, 8, 213-224.
6. Goode,E.L. et al. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev., 11, 1513-1530.
7. Wu,X. et al. (2007) Genetic polymorphism in bladder cancer. Front. Biosci., 12, 192-213.
8. Pharoah,P.D. et al. (2004) Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer, 4, 850-860.
9. Wu,X. et al. (2004) Genetic susceptibility to tobacco-related cancer. Oncogene, 23, 6500-6523.
10. Erichsen,H.C. et al. (2004) SNPs in cancer research and treatment. Br. J. Cancer, 90, 747-751.
11. Friedberg,E.C. (2001) How nucleotide excision repair protects against cancer. Nat. Rev. Cancer, 1, 22-33.
12. Wu,X. et al. (2006) Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet., 78, 464-479.
13. Andrew,A.S. et al. (2006) Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis, 27, 1030-1037.
14. Huang,M. et al. (2007) High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol. Biomarkers Prev., 16, 84-91.
15. Wu,X. et al. (2003) XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis, 24, 505-509.
16. Marin,M.S. et al. (2004) Poly (AT) polymorphism in intron 11 of the XPC DNA repair geng enhances the risk of lung cancer. Cancer Epidemiol. Biomakers Prev., 13, 1788-1793.
17. Pashos,C.L. et al. (2002) Bladder dancer: Epidemiology, diagnosis, and management. Cancer Pract., 10, 311-322.
18. Ross,R.K. et al. (1996) Bladder cancer epidemiology and pathogenesis. Semin. Oncol., 23, 536-545.
19. Hoeijmakers,J.H. et al. (1996) TFIIH: A key component in multiple DNA transactions. Curr. Opin. Genet. Dev., 6, 26-33.
20. Drapkin,R. et al. (1994) Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature, 368, 769-772.
21. Tang,D. et al. (2002) Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res. Treat., 75, 159-166.
22. Au,W.W. et al. (2003) Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect., 111, 1843-1850.
23. Lunn,R.M. et al. (2000) XPD polymorphisms: Effects on DNA repair proficiency. Carcinogenesis, 21, 551-555.
24. Seker,H. et al. (2001) Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res., 61, 7430-7434.
25. Benhamou,S. et al. (2005) ERCC2/XPD gene polymorphisms and lung cancer: A HuGE review. Am. J. Epidemiol., 161, 1-14.
26. Hu,Z. et al. (2004) DNA repair gene XPD polymorphism and lung cancer risk: A meta-analysis. Lung Cancer, 46, 1-10.
27. Tomescu,D. et al. (2001) Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22, 403-408.
28. Rybicki,B.A. et al. (2004) DNA repair gene XRCC1 and XPD polymorphisms and risk of. prostate cancer. Cancer Epidemiol. Biomarkers Prev., 13, 23-29.
29. Vogel,U. et al. (2001) Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis, 22, 899-904.
30. Garcia-Closas,M. et al. (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 536-542.
31. Ritchie,M.D. et al. (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J. Hum. Genet., 69, 138-147.
32. Xu,J. et al. (2065) The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol. Biomarkers Prev., 14, 2563-2568.
33. Matullo,G. et al. (2001) DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer, 92, 562-567.